Trial Profile
The Influence of Intranasal Oxytocin on Communication
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Lactation failure
- Focus Therapeutic Use
- 15 Apr 2019 Status changed from recruiting to completed.
- 27 Dec 2017 Planned number of patients changed from 600 to 200.
- 27 Dec 2017 Status changed from not yet recruiting to recruiting.